Contributing [acty]
Effectiveness [qlco]
Dipeptidyl Peptidase 4 [aapp, enzy, imft]
Inhibitor [qlco]
sitagliptin [orch, phsu]
Patients [podg]
Type 2 Diabetes [dsyn]
Purpose [ftcn]
treatment [ftcn]
Dipeptidyl-Peptidase 4 Inhibitors [phsu]
Agreement [socb]
effects [qlco]
Negative [qlco]
Efficacy [qlco]
Dipeptidyl-Peptidase 4 Inhibitors [phsu]
Lacking [qlco]
Present [qnco]
Study [mnob]
investigate [ftcn]
Resistance Factors [bacs, nnon]
Efficacy [qlco]
sitagliptin [orch, phsu]
Patients [podg]
Type 2 Diabetes [dsyn]
Methods [inpr]
Performed [ftcn]
Retrospective Study [resa]
Based [ftcn]
Medical Records [inpr]
Patients [podg]
treated [topp]
sitagliptin [orch, phsu]
Alone [qnco]
sitagliptin [orch, phsu]
N NOS [aapp, imft]
Combination [qlco]
Sulfonylurea [orch, phsu]
Dose [qnco]
ADD [mobd]
sitagliptin [orch, phsu]
Sulfonylurea [orch, phsu]
sitagliptin [orch, phsu]
N NOS [aapp, imft]
sitagliptin [orch, phsu]
Alone [qnco]
Discontinuation [hlca]
Premedication [topp]
Anti-diabetic Agent [phsu]
sitagliptin [orch, phsu]
AD [inpr]
N NOS [aapp, imft]
Combination [qlco]
Sulfonylurea [orch, phsu]
Dose [qnco]
reduction [npop]
sitagliptin [orch, phsu]
Sulfonylurea [orch, phsu]
sitagliptin [orch, phsu]
N NOS [aapp, imft]
Logistic Regression [resa]
Employed [fndg]
Estimate [qnco]
influential [idcn]
Resistance Factors [bacs, nnon]
Haemoglobin A1c [aapp, bacs]
lowering [spco]
sitagliptin [orch, phsu]
treatment [ftcn]
3 Months [tmco]
findings [ftcn]
HbA [aapp, bacs]
Levels [qlco]
treatment [ftcn]
sitagliptin [orch, phsu]
Sulfonylurea [orch, phsu]
sitagliptin [orch, phsu]
Sulfonylurea [orch, phsu]
sitagliptin [orch, phsu]
sitagliptin [orch, phsu]
AD [inpr]
baseline [bodm]
treatment [ftcn]
Logistic Regression [resa]
Established [qlco]
Decreased [qnco]
Efficacy [qlco]
sitagliptin [orch, phsu]
Markedly [qlco]
baseline [bodm]
HbA [aapp, bacs]
Levels [qlco]
Dyslipidaemia [dsyn]
journals [inpr, mnob]
Reserve [acty]
